Clinical Trial Update: "Monoclonal Antibodies for Treatment of Multiple Myeloma. Emphasis on the CD38 Antibody Daratumumab " [Phase 2, Phase 3]

View source ↗

Summary

This document reports a completed Phase 2 and Phase 3 trial update evaluating monoclonal antibodies for treating multiple myeloma, with emphasis on the CD38 ant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Daratumumab (daratumumab)

Snippet

Sponsor: Vejle Hospital | Conditions: Multiple Myeloma | Phase 2, Phase 3 | Status: COMPLETED